-
Mashup Score: 11Visa Wizard - 5 day(s) ago
× You are about to leave travel.state.gov for an external website that is not maintained by the U.S. Department of State. Links to external websites are provided as a convenience and should not be construed as an endorsement by the U.S. Department of State of the views or products contained therein. If you wish to remain on travel.state.gov, click the “cancel” message. Privacy | Copyright & Disclaimer | FOIA | No FEAR Act Data | Office of the Inspector General | USA.gov | USA.gov/espanol | This site is
Source: travel.state.govCategories: General Medicine NewsTweet
-
Mashup Score: 3
Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access. December 3rd 2024- Prof. Gili Kenet- Gene Therapy for Hemophilia November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies November 11th
Source: iach.orgCategories: General Medicine NewsTweet
-
Mashup Score: 3
Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access. December 3rd 2024- Prof. Gili Kenet- Gene Therapy for Hemophilia November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies November 11th
Source: iach.orgCategories: General Medicine NewsTweet
-
Mashup Score: 3
Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access. December 3rd 2024- Prof. Gili Kenet- Gene Therapy for Hemophilia November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies November 11th
Source: iach.orgCategories: General Medicine NewsTweet
-
Mashup Score: 3
Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access. December 3rd 2024- Prof. Gili Kenet- Gene Therapy for Hemophilia November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies November 11th
Source: iach.orgCategories: General Medicine NewsTweet
-
Mashup Score: 1
SAN DIEGO — Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood cancers, according to retrospective data presented at ASH Annual Meeting and Exposition. Patients with commercial insurance and Medicaid had prescriptions rejected more often than patients with Medicare.“When the new high-cost cholesterol-lowering
Source: www.healio.comCategories: General Medicine NewsTweet
-
Mashup Score: 8Highlights of ASH in Latin America - 3 month(s) ago
Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical hematology. April 25-26, 2025 Punta del Este Convention & Exhibition Center | Punta del Este, Uruguay Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research pre sented at the latest
Source: www.hematology.orgCategories: General Medicine NewsTweet
-
Mashup Score: 20Highlights of ASH® - 3 month(s) ago
Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies at Highlights of ASH.
Source: www.hematology.orgCategories: General Medicine NewsTweet-
Thanks to all who joined Highlights of ASH in the Mediterranean, Middle East, and North Africa! Learn the clinical applications of #ASH24 research in a small, interactive environment. Attend our final Highlights of ASH in Uruguay! https://t.co/1XPdxC35qv @b_avalos_MD @GCC_Cortes https://t.co/hJY9wp3jKf
-
-
Mashup Score: 0Beat AML trial: Updates from ASH 2024 - 3 month(s) ago
During the 66th ASH Annual Meeting and Exposition, the AML Hub was pleased to speak with Ashley Yocum, Leukemia & Lymphoma Society, about the latest updates from the Beat AML trial.
Source: aml-hub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Highlights of ASH in Latin America - 4 month(s) ago
Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical hematology. April 25-26, 2025 Punta del Este Convention & Exhibition Center | Punta del Este, Uruguay Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet
Planning on traveling to the U.S. for #ASH24? Find out if your country requires a visa: https://t.co/4WNfqPN9ci If so, here's 4⃣ things you need to know before arranging your trip 👇 https://t.co/vNNwEs6M1S